Pharma Business Week articles from December 2003

Pharma Business Week archives from December 2003

Data reported on monthly injectable sustained-release formulation of ZT-1.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- At the 4th Neurobiology of Aging Conference in New Orleans, Louisiana, Debiopharm S.A. (Debiopharm) presented the results of an in vivo evaluation in rats of an injectable once-monthly sustained-release...

Positive results reported on long-acting injectable insulin.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- BioSante Pharmaceuticals, Inc., (BPA) announced that positive results of preclinical testing of its calcium phosphate (CAP) delivery system for the injection of insulin were presented here at the third...

Niaspan launched in the United Kingdom.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Kos Pharmaceuticals, Inc., (KOSP) announced that Merck Pharmaceuticals, UK, a subsidiary of Merck, KGaA, Germany, has launched Niaspan (extended-release niacin) in the United Kingdom (U.K.), a...

Miikana Therapeutics inks strategic alliance for antibody development.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Miikana Therapeutics, Inc., and NovImmune, SA, have established a collaboration to develop fully human antibody-based therapeutics for the treatment of cancer and immune diseases. The resulting...

Research agreement signed for testing of topical anti-herpes formulations.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- CytoGenix, Inc., (CYGX) has signed an agreement with the DermPharm division of DermTech International, Inc., a firm specializing in dermatology safety and efficacy testing with experience in the U.S....

Study: Female sexual dysfunction drug market to grow 10% over next 5 years.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Decision Resources, Inc., forecasts that the female sexual dysfunction (FSD) drug market will grow 10% from 2002-2007. According to the new Pharmacor study entitled "Female Sexual Dysfunction," the...

New antibiotic - Cubicin - shipped to U.S. institutions.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Cubist Pharmaceuticals, Inc., (CBST) announced that it has begun shipping its flagship antibiotic product, Cubicin (daptomycin for injection), to U.S. hospitals. Cubist received U.S. Food & Drug...

Company works to amend its non-approvable New Drug Application.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Noven Pharmaceuticals, Inc., (NOVN) provided an update on the status of MethyPatch, its developmental methylphenidate transdermal system for attention deficit hyperactivity disorder. MethyPatch is...

FDA approval granted for loratadine.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Andrx Corporation (ADRX) announced that the U.S. Food and Drug Administration (FDA) has approved the marketing of its Abbreviated New Drug Application (ANDA) for its loratadine orally disintegrating...

Three disease compounds acquired from Sankyo.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- BTG (BGC) has acquired the intellectual property rights to a portfolio of preclinical compounds designed to treat Alzheimer disease, from Sankyo Co., Ltd., Japan. The portfolio encompasses three...

Infusions of synthetic HDL may remove plaque from coronary arteries.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- A new study appearing in the November 5 edition of the Journal of the American Medical Association provides strong evidence that five weekly infusions of a synthetic form of "good cholesterol," or HDL,...

Phase II data from study of ETC-216 show plaque accumulation can be reversed.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Esperion Therapeutics, Inc., (ESPR) announced the results of a study providing significant evidence that its investigational product candidate, ETC-216 (ApoA-I Milano/phospholipid complex or AIM),...

Stimulation of reverse cholesterol transport can result in regression of plaque.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Lipid Sciences, Inc., (LIPD), announced that an article published on November 5, 2003, in the Journal of the American Medical Association (JAMA), supports the premise on which its Vascular Lipid Removal...

Uroxatral launched in U.S. to treat symptoms of benign prostatic hyperplasia.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Sanofi-Synthelabo announced that Uroxatral (alfuzosin hydrochloride extended-release tablets) has been launched in the U.S. as a 10 mg, once-daily prescription alpha1-blocker that provides effective...

Benign prostatic hypertrophy drug available in U.S.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- SkyePharma PLC (SKYE) announced that Sanofi-Synthelabo (SNY) has launched Uroxatral (alfuzosin hydrochloride) in the U.S. market for the relief of urinary symptoms associated with benign prostatic...

Genome-wide human genetic variation map complete.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Applied Biosystems Group (ABI), an Applera Corporation business, announced that it has completed the development of a genome-wide human genetic variation map based on single nucleotide polymorphisms...

Perfluorocarbon-based blood substitute undergoes phase I clinical trial.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Synthetic Blood International Inc. (SYBD) announced that a phase I clinical trial of Oxycyte, its perfluorocarbon-based blood substitute, started on October 30, 2003, and believes that Oxycyte may be...

FDA gives approval for phase III registrational trial for breast cancer drug.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- YM BioSciences Inc. (YMBA) has received written confirmation from the U.S. Food and Drug Administration (FDA) that it may initiate a pivotal phase III, or registrational trial, for its lead...

Alliance targets siRNA research using GeneChip technology.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Qiagen N.V. (QGENF, QIA) and Affymetrix, Inc., (AFFX) announced that they have entered into a collaboration to optimize Qiagen siRNA-mediated gene silencing using Affymetrix GeneChip microarray...

Alliance with the Cleveland Clinic uses imaging system in cancer research.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Applied Imaging Corp. announced the formation of a clinical research imaging collaboration with the Department of Anatomic Pathology at The Cleveland Clinic Foundation. As part of this...

AlphaNet to provide services to emphysema patients who rely on Zemaira.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Aventis Behring, LLC, announced an agreement with AlphaNet, Inc., a not-for-profit health management company, to provide health management and support services to patients who rely on Zemaira...

Company gets $20M from Bristol-Myers Squibb as part of Basulin project.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Flamel Technologies (FLML) announced the receipt of the $20 million upfront payment from Bristol-Myers Squibb in respect of its Basulin project. Flamel's cash and cash equivalents are approximately...

Haemonetics announces intent to sign distribution agreement with French firm.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Haemonetics Corp. (HAE) and Hemosystem, S.A., announced that the companies have signed an agreement confirming each party's intent to enter an agreement for Haemonetics' exclusive marketing and...

IDI inks agreements regarding its real-time diagnostic products.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Infectio Diagnostic, Inc., (IDI) and Cepheid have concluded new agreements and have decided to terminate current ARIDIA joint venture. These new agreements will enable IDI and Cepheid to increase...

Marketing agreement signed for Collagenase Santyl Ointment.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- BioSpecifics Technologies Corp. (BSTC) announced that the Ross Products Division of Abbott Laboratories, Inc., will assume United States marketing responsibility for Collagenase Santyl Ointment...

Medarex announces achievement of milestone in agreement.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Medarex, Inc., (MEDX) has achieved a significant milestone under its 1999 agreement with Amgen, Inc. The achievement of this milestone will trigger an undisclosed payment to Medarex. "We are...

Partnership with Infectio Diagnostics restructured.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Cepheid (CPHD) announced that Cepheid and Infectio Diagnostics, Inc., (IDI) of Quebec, Canada, have executed a series of new agreements resulting in a restructuring of their previously existing...

Preliminary agreement for Sucanon sales in Mexico concluded.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Robert Rieveley, the president of Biotech Holdings (BIO.V, BIOHF.OB), announced that the company has concluded a preliminary agreement with a marketing company who will bring the company's Sucanon...

Research alliance to combine reverse transfection and siRNA.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Dharmacon, Inc., a supplier of RNA and RNA interference (RNAi) research products, and Akceli, Inc., a cellular systems biology company, announced a research collaboration to study the utility of...

Protein engineering firm moves facilities.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- BioTech Studio LLC, a new company offering to engineer proteins for the pharmaceutical industry, has moved into the region's premier life science and technology business incubator, the Science Center...

Patient enrollment initiated in study of vascular sealant product.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Closure Medical Corporation (CLSR) announced the first use in humans of its synthetic vascular sealant product under the company's U.S. Food and Drug Administration (FDA)-approved clinical trial. ...

Drug use climbed in the U.S. workforce in the first half of 2003.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Drug use in the general U.S. workforce climbed in the first half of 2003, driven by continued growth in the use of amphetamines, according to the semi-annual Drug Testing Index released by Quest...

Midwest research looks at cows to produce vaccines.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Research to help defend against diseases that could be spread by bioterrorists is being carried out in the pastures of northwest Iowa. Calves have been genetically engineered to produce human...

Positive study results released on GPCR targeted library.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- The Genomics Institute of the Novartis Research Foundation (GNF) and ChemBridge Research Laboratories, LLC, (CRL) announced results on GNF's evaluation of CRL's GPCR Targeted Library. Key...

Company reaches milestones in two research alliances with Baxter Healthcare.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Jerini, AG, has successfully passed first milestones in two research alliances entered into with Baxter in 2001 and 2002. Jerini has optimized peptide lead molecules identified against two...

Lilly purchases integrated cellular screening system.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Amersham (AHM) announced that Eli Lilly and Co. (LLY) has purchased an integrated suite of cellular screening technology and licenses to help in the identification of potential therapeutics in its drug...

Research agreement supports computer-assisted molecular design of medicines.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Shionogi & Co., Ltd., has entered into a joint research agreement with Professor Shin-ichiro Nishimura of the Hokkaido University Faculty of Science to use carbohydrate-related functional bioinformatic...

Scientists predict success of biomedical intervention against rapidly evolving organisms.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Viruses, bacteria, eukaryotic parasites, cancer cells, agricultural pests, and other inconvenient animates have the unfortunate feature to escape from selection pressures that are meant to control them....

Primary endpoints met in phase IIb study of erectile dysfunction drug.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Palatin Technologies, Inc., (PTN) announced the presentation of positive safety and efficacy data from its phase IIb "at home" study of PT-141 for male sexual dysfunction. Men with erectile...

Assay maker reports loss of $0.14 per share.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Aclara BioSciences (ACLA) reported financial results for the 3 months ended September 30, 2003. Revenue for the 3 months ended September 30, 2003, was $276,000, compared to revenue for the 3 months...

Biotech company reports 6% increase in sales.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- BioSource International, Inc., (BIOI) announced its operating results for the third quarter and 9 months ended September 30, 2003. Net sales for the 3 months ended September 30, 2003, were $10.7...

Biotech company reports loss of $0.21 per share.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Array BioPharma, Inc., (ARRY) reported financial results for the first quarter of fiscal 2004, ended September 30, 2003. During the first quarter of fiscal 2004, Array reported total revenue of...

Biotech firm raises $22M in private equity transaction.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- EntreMed, Inc., (ENMD) has raised approximately $22.3 million in gross proceeds in an issuance of common stock and warrants to certain independent institutional investors. Proceeds from the...

Cell therapy company launches direct stock purchase program.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Aastrom Biosciences, Inc., (ASTM) announced that registered shareholders of the company can purchase up to an aggregate of 10 million newly issued shares of its stock through Aastrom's Direct Stock...

Chemistry drug company reports 41.6% increase n revenue.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Albany Molecular Research, Inc., (AMRI) reported financial results for the quarter and 9-month period ending September 30, 2003. Total revenue for the third quarter of 2003 increased by $13.3...

Drug delivery company reports loss of $0.31 per share.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Alkermes, Inc., (ALKS) reported its financial results for the 3-month period ended September 30, 2003. The net loss on a GAAP basis for the quarter ended September 30, 2003, was $26.2 million or...

Enzyme Therapy maker reports quarterly loss of $0.33 per share.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- BioMarin Pharmaceutical, Inc., (BMRN) announced financial results for its third quarter ended September 30, 2003. The net loss was $21.3 million ($0.33 per share) for the third quarter of 2003...

Flavin Ventures announces funding of proteomic service provider.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Flavin Ventures has announced the start up and funding of its first new biotechnology venture since its recent establishment. Flavin Ventures has helped launch Shamrock Structures, a Chicago,...

Follow-on offering reported by pharmaceutical firm; guidance issued.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Bradley Pharmaceuticals, Inc., (BDY) announced that it has filed a Registration Statement on Form S-3 with the U.S. Securities and Exchange Commission relating to a proposed follow-on offering of...

Generic drug maker reports 38.9% increase in sales.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Able Laboratories, Inc., (ABRX, AAB) announced financial results for the 3 months ended September 30, 2003. For the third quarter of 2003, the company reported net sales of $20.9 million, a 38.9%...

Genomics company reports loss of $0.01 per share.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Epoch Biosciences, Inc., (EBIO) reported revenues for the third quarter of $2.0 million compared to $2.7 million in the like period in 2002, which included $686,000 of revenue from the San Diego,...

Genomics company reports loss of $0.35 per share; provides pipeline update.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Exelixis, Inc., (EXEL) reported financial results for the quarter ended September 30, 2003. For the quarter ended September 30, 2003, the company reported a net loss of approximately $25.0 million,...

Immunotherapeutics company reports $7.4M in revenue.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Corixa Corp. (CRXA) announced financial results for the third quarter ended September 30, 2003. The company also announced it is restructuring its operations to focus on priority programs and...

Inflammatory diseases drug maker files resale registration statement with SEC.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- AtheroGenics, Inc., (AGIX) announced that it has filed a resale registration statement on Form S-3 with the U.S. Securities and Exchange Commission (SEC) pertaining to its Convertible Notes issued on...

Insulin system maker reports loss of $0.08 per share.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Aradigm Corporation (ARDM) announced financial results for the third quarter and 9 months ended September 30, 2003. Contract revenues for the quarter were $9.8 million, compared to $6.0 million for...

Metabolic disease drug maker reports loss of $0.40 per share.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Amylin Pharmaceuticals, Inc., (AMLN) reported financial results for the third quarter ended September 30, 2003. The company reported a net loss of $37.5 million, or $0.40 per share, and $105.5...

Microfluidics company reports loss of $0.37 per share.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Caliper Technologies Corp. (CALP) announced its third quarter 2003 financial results. These results include the financial results of Zymark Corporation from July 14, 2003, (the acquisition date)...

Neugene maker reports net loss of $0.15 per share.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- AVI BioPharma, Inc., (AVII) reported financial results for the 3 and 9 months ended September 30, 2003, and provided an update on its clinical pipeline. For the third quarter of 2003, the company...

Neurological disease biotech company reports loss of $0.07 per share.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Axonyx, Inc., (AXYX) announced its results for the third quarter ended September 30, 2003. The company reported a net loss to shareholders of $1,803,000 or $0.07 per share for the third quarter of...

Offering of 35M shares closed by pharmaceutical firm.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Elan Corporation, plc, (ELN) announced that it has completed the offering and sale of 35 million ordinary shares at a price of $4.95 per share. Elan also announced that it expected to complete the...

Oncology company reports loss of $0.19 per share.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Allos Therapeutics, Inc., (ALTH) reported financial results for the third quarter of 2003. For the 3 months ended September 30, 2003, the company reported a net loss of $5.0 million, or $0.19 per...

Oncology drug maker reports $0.08 per share loss.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Cytogen Corporation (CYTO) reported its consolidated financial results for the 3- and 9-month periods ended September 30, 2003. Total revenues were $5.51 million for the third quarter of 2003...

Pain management drug maker announces pricing of common stock.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Adolor Corporation (ADLR) announced the pricing of a public offering of 6,000,000 shares of its common stock at $17.25 per share. The gross proceeds from the offering are expected to be $103.5...

Pain medication maker reports royalty income increased 23%.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- A.P. Pharma, Inc., (APPA) reported financial results for the 3 months ended September 30, 2003, reflecting increased royalty income and contract revenues. A.P. Pharma reported that total revenues...

Pharmaceutical company announces third quarter 2003 financial results.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Rigel Pharmaceuticals, Inc., (RIGL) reported financial results for the third quarter and 9 months that ended September 30, 2003. Rigel reported revenue from collaborations of $2.1 million in the...

Pharmaceutical company boosts sales by 13% worldwide.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Altana AG (AAA; ALT) reported sales of around EUR 2 billion for the first 9 months of 2003, up 5% on the equivalent previous year's figure. "Despite the worldwide economic slump, the weak dollar,...

Pharmaceutical company reports 63% increase in net income in third quarter.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Teva Pharmaceutical Industries Ltd. (TEVA) reported net income of $157 million for the third quarter of 2003, up 63%. Fully diluted EPS reached $0.53, up 47%, and net sales for the quarter...

Pharmaceutical company reports net loss in third quarter 2003.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Sonus Pharmaceuticals, Inc., (SNUS) reported financial results for the third quarter ended September 30, 2003. For the third quarter of 2003, Sonus reported a net loss of $2.5 million, or $0.15 per...

Physician services provider reports record third quarter results.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Pediatrix Medical Group, Inc., (PDX) reported record earnings per share of 97 cents for the 3 months ended September 30, 2003, up 33% from the prior year. Highlights for the 3 months ended September...

Proteomics device maker reports 12% increase in revenue.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Bruker BioSciences Corporation (BRKR) reported its financial results for the third quarter and the 9 months ended September 30, 2003. On July 1, 2003, Bruker Daltonics, Inc., merged with Bruker AXS,...

Radiopharmaceuticals company reports 46% revenue growth.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Draxis Health, Inc., (DAX, DRAX) reported operating results for the third quarter of 2003 ended September 30, 2003. Revenues from continuing operations in the third quarter 2003 were $13.0 million,...

Seasonale maker reports 41% increase in revenue.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Barr Laboratories, Inc., (BRL) reported net earnings of $38.5 million, or $0.55 per fully diluted share for the first quarter of fiscal 2004 ended September 30, 2003, as compared to net earnings of...

Sexual dysfunction drug maker completes $2M financing.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Enhance Biotech, Inc., (EBOI) announced that the company has completed a private equity financing of $2.0 million through the sale of common stock and warrants. The company will be using these funds...

Small molecule drug developer reports income of $0.11 per share.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Curis, Inc., (CRIS), a therapeutic drug development company, reported its financial results for the quarter ended September 30, 2003. For the third quarter of 2003, the company reported net income...

Third quarter service revenue rises 25% at imaging company.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Bio-Imaging Technologies, Inc., (BIT) announced its financial results for the third quarter and 9 months ended September 30, 2003. Total revenue for the third quarter of 2003 reached $6.3 million,...

Tissue processing company reports loss of $0.24 per share.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- CryoLife, Inc., (CRY), a human tissue processing and bio-surgical device company, reported financial results for the third quarter 2003. Revenues for the third quarter 2003 were $15.1 million...

Tissue, bone repair company posts 27% increase in revenue.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Anika Therapeutics, Inc., (ANIK) announced financial results for the third quarter and 9-months ended September 30, 2003. For the third quarter, Anika posted revenue of $3,688,000, a 27% increase,...

Broad potential reported for R1549 highlighted by favorable tolerability profile.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Antisoma plc, announced final results from its pilot phase II study of R1549 in gastric cancer. The trial, which has been funded since November 2002 by Antisoma's co-development partner, Roche,...

Gene vector for HIV cleared to begin phase I/II trial.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Enzo Biochem, Inc., (ENZ) announced that Enzo Therapeutics, its wholly owned subsidiary, has been cleared to proceed with a phase I/II study of its Stealth Vector HGTV43 gene construct for HIV infection...

Preclinical development program initiated for new HIV vaccine candidate.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- The Immune Response Corporation (IMNR) has initiated a preclinical development program with IR103, a new vaccine candidate for the prevention and treatment of HIV, the virus that causes AIDS. The...

AdvancePCS enhances consumer-directed pharmacy benefit services.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- AdvancePCS (ADVP) announced the launch of additional consumer-directed pharmacy benefit options, offering clients the opportunity to reduce health care spending while providing members with greater and...

Albumin reduces mortality in coronary artery bypass graft surgery.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- According to a recently published study, albumin, used as a blood volume expander in coronary artery bypass graft (CABG) surgery, is associated with a significantly lower incidence of mortality compared...

ADHERE patient registry reaches 100,000-case milestone.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Scios, Inc., announced the achievement of a new target milestone with the registration of 100,000 patient cases from more than 275 hospitals into ADHERE (Acute Decompensated Heart Failure National...

Supplement filed for approval of needless device used with Kogenate FS.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Bayer Biological Products (BP) announced the filing of a pre-approval supplement for Bio-Set, a new needleless device for the reconstitution and use of Kogenate FS (Antihemophilic Factor [Recombinant],...